Clinical Trials Browser

Phase 1 × Recurrence × MAC-ST-001 × Clear all

NCT06922539 2025-12-15

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Phase 1 Recruiting

Recurrence, Small Cell Lung Carcinoma